Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 226 AL 240

Multicenter (18)F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's Disease

Rullmann M, Brendel M, Schroeter ML, Saur D, Levin J, Perneczky RG, Tiepolt S, Patt M, Mueller A, Villemagne VL, Classen J, Stephens AW, Sabri O, Barthel H, On Behalf Of The German Imaging Initiative For Tauopathies Gii T.

Biomolecules. 2022 Mar 16;12(3):458. doi: 10.3390/biom12030458.

Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors

George G, Koyiparambath VP, Sukumaran S, Nair AS, Pappachan LK, Al-Sehemi AG, Kim H, Mathew B.

Int J Mol Sci. 2022 Mar 14;23(6):3121. doi: 10.3390/ijms23063121.

Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders

Ranjan AK, Gulati A.

Int J Mol Sci. 2022 Mar 15;23(6):3146. doi: 10.3390/ijms23063146.

Regulatory miRNAs in Cardiovascular and Alzheimer's Disease: A Focus on Copper

Sacco A, Martelli F, Pal A, Saraceno C, Benussi L, Ghidoni R, Rongioletti M, Squitti R.

Int J Mol Sci. 2022 Mar 19;23(6):3327. doi: 10.3390/ijms23063327.

Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes

Gómez-Isla T, Frosch MP.

Nat Rev Neurol. 2022 Jun;18(6):323-332. doi: 10.1038/s41582-022-00642-9. Epub 2022 Mar 24.

[Relationship between Oral Microbiota and Alzheimer's Disease]

Li YC, Liu Y, Chen F, Chu M, Chen XC.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Mar;53(2):194-200. doi: 10.12182/20220360304.

Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease

Singh SK, Balendra V, Obaid AA, Esposto J, Tikhonova MA, Gautam NK, Poeggeler B.

Metallomics. 2022 Jun 13;14(6):mfac018. doi: 10.1093/mtomcs/mfac018.

Role of Cholinergic Signaling in Alzheimer's Disease

Chen ZR, Huang JB, Yang SL, Hong FF.

Molecules. 2022 Mar 10;27(6):1816. doi: 10.3390/molecules27061816.

The war against Alzheimer, the mitochondrion strikes back!

Zambrano K, Barba D, Castillo K, Robayo P, Argueta-Zamora D, Sanon S, Arizaga E, Caicedo A, Gavilanes AWD.

Mitochondrion. 2022 May;64:125-135. doi: 10.1016/j.mito.2022.03.003. Epub 2022 Mar 23.

Multiple Cortical to Striatal Accumulation Trajectories of β-Amyloid: Do All Roads Lead to Rome?

Vogel JW, Tosun D.

Neurology. 2022 Apr 26;98(17):695-696. doi: 10.1212/WNL.0000000000200191. Epub 2022 Mar 25.

Effects of multisite anodal transcranial direct current stimulation combined with cognitive stimulation in patients with Alzheimer's disease and its neurophysiological correlates: A double-blind randomized clinical trial

Andrade SM, Machado DGDS, Silva-Sauerc LD, Regis CT, Mendes CKTT, de Araújo JSS, de Araújo KDT, Costa LP, Queiroz MEBS, Leitão MM, Fernández-Calvo B.

Neurophysiol Clin. 2022 Apr;52(2):117-127. doi: 10.1016/j.neucli.2022.02.003. Epub 2022 Mar 24.

Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures

Kim CK, Lee YR, Ong L, Gold M, Kalali A, Sarkar J.

J Alzheimers Dis. 2022;87(1):83-100. doi: 10.3233/JAD-215699.

Applications and Outcomes of Internet of Things for Patients with Alzheimer's Disease/Dementia: A Scoping Review

Sheikhtaheri A, Sabermahani F.

Biomed Res Int. 2022 Mar 15;2022:6274185. doi: 10.1155/2022/6274185. eCollection 2022.

Pharmacological Exploration of Triazole-based Therapeutics for Alzheimer's Disease: An Overview

Prasanna CAL, Sharma A.

Curr Drug Targets. 2022;23(9):933-953. doi: 10.2174/1389450123666220328153741.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias